Global Breast Biopsy Devices Market, By Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems, Others), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization, Sentinel Node Biopsy), Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy, Other Image-Guided Breast Biopsy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other),Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
The breast biopsy devices marketis expected to witness market growth at a rate of 6.95% in the forecast period of 2021 to 2028. Data Bridge Market Research report on breast biopsy devices market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth.The rise in the healthcare sector globally is escalating the growth of breast biopsy devices market.
Breast biopsy devices refer to the type of medical devices that are used for the breast biopsy procedures. The biopsy includes the surgical removal of tissue or fluid for examination and determination of any possible disease. The presence of breast cancer is checked by examining the removed tissueunder microscopes. These samples are sent to the testing laboratories where the diagnosing is done with the help of various tools and devices such as needles, tables, and wires among others.
The increasing incidences of breast canceramong female population across the globe acts as one of the major factors driving the growth of breast biopsy devices market.The rise in number of breast cancer screening programs owning to government efforts and increase in demand for minimally invasive and non-invasive procedures because of its various advantages such as fast recovery and less pain accelerate the market growth. The growth in awareness regarding early detection of breast cancer and the improved reimbursement scenario further influence the market growth. Additionally, rise in population, surge in healthcare expenditure, and rise in initiatives by public organizations towards female health problems positively affects thebreast biopsy devices market. Furthermore, emergence of liquid biopsy and promising clinical trials extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, the risk of infections associated with the use of biopsy needles and stringent regulatory approval procedures are expected to obstruct the market growth.Underdeveloped healthcare infrastructure and lack of resources in developing countries are projected to challenge the breast biopsy devices marketin the forecast period of 2021-2028.
This breast biopsy devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on breast biopsy devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Breast Biopsy Devices Market Scope and Market Size
The breast biopsy devices market is segmented on the basis of product, technique type, guidance technology and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the breast biopsy devices market is segmented into biopsy needles, biopsy tables, biopsy wires, guidance systems and others.
- On the basis of technique type, the breast biopsy devices market is segmented into fine needle aspiration biopsy, core needle biopsy, biopsy markers, MRI-guided core needle biopsy, surgical biopsy, wire localization, and sentinel node biopsy.
- On the basis of guidance technology, the breast biopsy devices market is segmented into fine ultrasound-guided, mammography-guided magnetic resonance, CT-guided biopsy, and other image-guided breast biopsy.
- On the basis of end user, the breast biopsy devices market is segmented into hospitals, ambulatory surgical centres, and diagnostic centres and other.
Breast Biopsy Devices Market Country Level Analysis
The breast biopsy devices market is analyzed and market size insights and trends are provided by country, product, technique type, guidance technology and end useras referenced above.
The countries covered in the breast biopsy devices market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the breast biopsy devices market because of thefavourable reimbursement policies and developed healthcare infrastructure within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the evolving healthcare infrastructure in emerging economies such as China, India, and South Korea.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The breast biopsy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for breast biopsy devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the breast biopsy devices market. The data is available for historic period 2010-2019.
Competitive Landscape and Breast Biopsy Devices Market Share Analysis
The breast biopsy devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to breast biopsy devices market.
The major players covered in the breast biopsy devices market report areScion Medical Technologies LLC, STERYLAB S.r.l., ARGON MEDICAL, Danaher, Cianna Medical, Benetec, Cigna, United Medical Systems Inc., Stryker, BD, Hologic Inc., Devicor Medical Products Inc., F. Hoffmann-La Roche Ltd, OncoCyte Corporation, Cook, Siemens, Medtronic, SOMATEX Medical Technologies GmbH, Trivitron Healthcare, Vigeosrl, Johnson & Johnson Services Inc., Boston Scientific Corporation, Olympus Corporation, FUJIFILM Holdings Corporation, GENERAL ELECTRIC, Cardinal Health and B. Braun Melsungen AG, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Breast Biopsy Devices Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.